1 / 3
google
Article details
- Package size
- 85,5
- Selling units
- 85
- Measure
- g
- Galenic form
- Gel
- Galenic group
- Salben
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.71 G | Substance | Wirkstoff (Principe actif) |
|
ethanolum 96 per centum
|
540.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
diethylenglycoli monoethylicum aetherum
|
- | Substance | HNIDK |
|
carbomerum 980
|
- | Substance | HNIDK |
|
trolaminum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 66816
- Drug name
- Testavan, Gel
- Galenic form
- GELK
- ATC Code
- G03BA03
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 12/06/2019
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.08.4.
- Domain
- Human medicine
Package details
- Description (FR)
- TESTAVAN gel 23 mg fl dos 85.5 g
- Description (DE)
- TESTAVAN Gel 23 mg Dosierfl 85.5 g
- Market launch
- 12/06/2019
- Narcotic (BTM)
- No